ATEX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Anterix Inc (ATEX) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company shows promising financial growth and operational improvements, the recent price decline, lack of strong trading signals, and limited upside potential as per analysts suggest holding off on immediate investment. The investor may consider monitoring the stock for further developments or a more favorable entry point.
The technical indicators are mixed. The MACD is positive but contracting, RSI is neutral at 51.097, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock closed below the pivot level of 74.558, with key support at 64.391 and resistance at 84.725. The recent price drop of -5.85% in regular trading and -1.05% post-market indicates bearish sentiment.
Anterix reported positive cash flows of $127 million in fiscal 2026, ending the year with over $98 million in cash and no debt.
Signed four new utility contracts in three months, reflecting strong market demand.
Strong Q4 revenue growth of 41% year-over-year and a full-year GAAP EPS of $4.83, showcasing financial health and growth potential.
Appointment of a new Chief Revenue Officer to enhance commercial execution.
Analysts downgraded the stock to Neutral with a limited upside, citing ongoing uncertainty around monetizing 900 MHz spectrum holdings.
The stock price has declined significantly in the regular and post-market sessions.
No significant hedge fund or insider trading activity to indicate strong institutional confidence.
Anterix delivered strong financial results in fiscal 2026, with positive cash flows of $127 million, ending the year with $98 million in cash and no debt. Q4 revenue increased by 41% year-over-year to $1.96 million, and the company reported a Q4 profit of $18.52 million, up from $9.21 million last year. Despite missing Q4 GAAP EPS expectations, the full-year GAAP EPS of $4.83 indicates overall financial health.
B. Riley downgraded the stock to Neutral from Buy, with a price target of $69 (up from $44). Analysts see limited upside due to ongoing challenges in monetizing spectrum holdings, despite the strategic importance of the asset and potential for a near-term deal.
